Cytokine-induced MMP13 Expression in Human Chondrocytes Is Dependent on Activating Transcription Factor 3 (ATF3) Regulation. 2017

Chun Ming Chan, and Christopher D Macdonald, and Gary J Litherland, and David J Wilkinson, and Andrew Skelton, and G Nicholas Europe-Finner, and Andrew D Rowan
From the Musculoskeletal Research Group, Institute of Cellular Medicine, Newcastle University, Framlington Place, Newcastle-upon-Tyne NE2 4HH, United Kingdom.

Irreversible breakdown of cartilage extracellular matrix (ECM) by the collagenase matrix metalloproteinase 13 (MMP13) represents a key event in osteoarthritis (OA) progression. Although inflammation is most commonly associated with inflammatory joint diseases, it also occurs in OA and is thus relevant to the prevalent tissue destruction. Here, inflammation generates a cFOS AP-1 early response that indirectly affects MMP13 gene expression. To ascertain a more direct effect on prolonged MMP13 production we examined the potential molecular events occurring between the rapid, transient expression of cFOS and the subsequent MMP13 induction. Importantly, we show MMP13 mRNA expression is mirrored by nascent hnRNA transcription. Employing ChIP assays, cFOS recruitment to the MMP13 promoter occurs at an early stage prior to gene transcription and that recruitment of transcriptional initiation markers also correlated with MMP13 expression. Moreover, protein synthesis inhibition following early FOS expression resulted in a significant decrease in MMP13 expression thus indicating a role for different regulatory factors modulating expression of the gene. Subsequent mRNA transcriptome analyses highlighted several genes induced soon after FOS that could contribute to MMP13 expression. Specific small interfering RNA-mediated silencing highlighted that ATF3 was as highly selective for MMP13 as cFOS. Moreover, ATF3 expression was AP-1(cFOS/cJUN)-dependent and expression levels were maintained after the early transient cFOS response. Furthermore, ATF3 bound the proximal MMP13 AP-1 motif in stimulated chondrocytes at time points that no longer supported binding of FOS Consequently, these findings support roles for both cFOS (indirect) and ATF3 (direct) in effecting MMP13 transcription in human chondrocytes.

UI MeSH Term Description Entries
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D015971 Gene Expression Regulation, Enzymologic Any of the processes by which nuclear, cytoplasmic, or intercellular factors influence the differential control of gene action in enzyme synthesis. Enzymologic Gene Expression Regulation,Regulation of Gene Expression, Enzymologic,Regulation, Gene Expression, Enzymologic
D016755 Proto-Oncogene Proteins c-jun Cellular DNA-binding proteins encoded by the c-jun genes (GENES, JUN). They are involved in growth-related transcriptional control. There appear to be three distinct functions: dimerization (with c-fos), DNA-binding, and transcriptional activation. Oncogenic transformation can take place by constitutive expression of c-jun. c-fos-Associated Protein p39,c-jun Proteins,fos-Associated Protein p39,jun B Proteins,jun D Proteins,jun Proto-Oncogene Proteins,p39(c-jun),Proto-Oncogene Products c-jun,Proto-Oncogene Proteins jun,jun Proto-Oncogene Product p39,p39 c-jun,Proto Oncogene Products c jun,Proto Oncogene Proteins c jun,Proto Oncogene Proteins jun,c fos Associated Protein p39,c jun Proteins,fos Associated Protein p39,jun Proto Oncogene Product p39,jun Proto Oncogene Proteins,p39 c jun
D016760 Proto-Oncogene Proteins c-fos Cellular DNA-binding proteins encoded by the c-fos genes (GENES, FOS). They are involved in growth-related transcriptional control. c-fos combines with c-jun (PROTO-ONCOGENE PROTEINS C-JUN) to form a c-fos/c-jun heterodimer (TRANSCRIPTION FACTOR AP-1) that binds to the TRE (TPA-responsive element) in promoters of certain genes. Fos B Protein,Fos-Related Antigen,Fos-Related Antigens,c-fos Protein,c-fos Proteins,fos Proto-Oncogene Protein,fos Proto-Oncogene Proteins,p55(c-fos),Antigens, Fos-Related,FRAs,Proto-Oncogene Products c-fos,Proto-Oncogene Proteins fos,p55 c-fos,Antigen, Fos-Related,Fos Related Antigen,Fos Related Antigens,Protein, c-fos,Protein, fos Proto-Oncogene,Proto Oncogene Products c fos,Proto Oncogene Proteins c fos,Proto Oncogene Proteins fos,Proto-Oncogene Protein, fos,c fos Protein,c fos Proteins,fos Proto Oncogene Protein,fos Proto Oncogene Proteins,p55 c fos
D051700 Activating Transcription Factor 3 An activating transcription factor that plays a key role in cellular responses to GENOTOXIC STRESS and OXIDATIVE STRESS. ATF3 Transcription Factor,Activating Transcription Factor-3,Transcription Factor, ATF3
D053509 Matrix Metalloproteinase 13 A secreted matrix metalloproteinase that plays a physiological role in the degradation of extracellular matrix found in skeletal tissues. It is synthesized as an inactive precursor that is activated by the proteolytic cleavage of its N-terminal propeptide. Collagenase 3,Collagenase-3,MMP-13 Metalloproteinase,MMP13 Metalloproteinase,Matrix Metalloproteinase-13,MMP 13 Metalloproteinase,Metalloproteinase 13, Matrix,Metalloproteinase, MMP-13,Metalloproteinase, MMP13,Metalloproteinase-13, Matrix
D059467 Transcriptome The pattern of GENE EXPRESSION at the level of genetic transcription in a specific organism or under specific circumstances in specific cells. Transcriptomes,Gene Expression Profiles,Gene Expression Signatures,Transcriptome Profiles,Expression Profile, Gene,Expression Profiles, Gene,Expression Signature, Gene,Expression Signatures, Gene,Gene Expression Profile,Gene Expression Signature,Profile, Gene Expression,Profile, Transcriptome,Profiles, Gene Expression,Profiles, Transcriptome,Signature, Gene Expression,Signatures, Gene Expression,Transcriptome Profile
D018808 Transcription Factor AP-1 A multiprotein complex composed of the products of c-jun and c-fos proto-oncogenes. These proteins must dimerize in order to bind to the AP-1 recognition site, also known as the TPA-responsive element (TRE). AP-1 controls both basal and inducible transcription of several genes. AP-1 Enhancer-Binding Protein,AP-1,AP-1 Enhancer Binding Protein,Activator Protein-1,AP 1 Enhancer Binding Protein,Activator Protein 1,Enhancer-Binding Protein, AP-1,Transcription Factor AP 1
D019902 Chondrocytes Polymorphic cells that form cartilage. Chondroblasts,Chondroblast,Chondrocyte

Related Publications

Chun Ming Chan, and Christopher D Macdonald, and Gary J Litherland, and David J Wilkinson, and Andrew Skelton, and G Nicholas Europe-Finner, and Andrew D Rowan
August 2010, Experimental dermatology,
Chun Ming Chan, and Christopher D Macdonald, and Gary J Litherland, and David J Wilkinson, and Andrew Skelton, and G Nicholas Europe-Finner, and Andrew D Rowan
March 2007, Molecular immunology,
Chun Ming Chan, and Christopher D Macdonald, and Gary J Litherland, and David J Wilkinson, and Andrew Skelton, and G Nicholas Europe-Finner, and Andrew D Rowan
January 2013, PloS one,
Chun Ming Chan, and Christopher D Macdonald, and Gary J Litherland, and David J Wilkinson, and Andrew Skelton, and G Nicholas Europe-Finner, and Andrew D Rowan
January 2021, International journal of general medicine,
Chun Ming Chan, and Christopher D Macdonald, and Gary J Litherland, and David J Wilkinson, and Andrew Skelton, and G Nicholas Europe-Finner, and Andrew D Rowan
January 2022, Frontiers in cell and developmental biology,
Chun Ming Chan, and Christopher D Macdonald, and Gary J Litherland, and David J Wilkinson, and Andrew Skelton, and G Nicholas Europe-Finner, and Andrew D Rowan
January 2013, PloS one,
Chun Ming Chan, and Christopher D Macdonald, and Gary J Litherland, and David J Wilkinson, and Andrew Skelton, and G Nicholas Europe-Finner, and Andrew D Rowan
May 2005, Molecular cancer therapeutics,
Chun Ming Chan, and Christopher D Macdonald, and Gary J Litherland, and David J Wilkinson, and Andrew Skelton, and G Nicholas Europe-Finner, and Andrew D Rowan
December 2017, Journal of cellular physiology,
Chun Ming Chan, and Christopher D Macdonald, and Gary J Litherland, and David J Wilkinson, and Andrew Skelton, and G Nicholas Europe-Finner, and Andrew D Rowan
January 2005, Scandinavian journal of plastic and reconstructive surgery and hand surgery,
Chun Ming Chan, and Christopher D Macdonald, and Gary J Litherland, and David J Wilkinson, and Andrew Skelton, and G Nicholas Europe-Finner, and Andrew D Rowan
December 2008, Atherosclerosis,
Copied contents to your clipboard!